CAS 200393-05-1|Adenosylmethionine 1,4-butanedisulfonate
| Common Name | Adenosylmethionine 1,4-butanedisulfonate | ||
|---|---|---|---|
| CAS Number | 200393-05-1 | Molecular Weight | 598.67100 |
| Density | / | Boiling Point | / |
| Molecular Formula | C19H30N6O10S3 | Melting Point | / |
| MSDS | / | Flash Point | / |
Names
| Name | (2S)-2-({[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-{[( 4-sulfobutyl)sulfonyl]oxy}tetrahydro-2-furanyl]methyl}amino)-4-(m ethylsulfanyl)butanoic acid (non-preferred name) |
|---|---|
| Synonym | More Synonyms |
Adenosylmethionine 1,4-butanedisulfonate BiologicalActivity
| Description | S-Adenosyl-L-methionine (S-Adenosyl methionine) 1,4-butanedisulfonate is an orally active methyl group donor. S-Adenosyl-L-methionine 1,4-butanedisulfonate is a dietary supplement with potent antidepressant effects. S-Adenosyl-L-methionine 1,4-butanedisulfonate also has anti‑proliferative, pro‑apoptotic and anti‑metastatic roles in cancers. S-Adenosyl-L-methionine 1,4-butanedisulfonate has the potential for, cancer, liver disease and osteoarthritis research[1][2][3]. |
|---|---|
| Related Catalog | Signaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>CancerResearch Areas >>Inflammation/ImmunologyResearch Areas >>Neurological Disease |
| References | [1]. G M Bressa. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol Scand Suppl. 1994;154:7-14. [2]. Wadie I Najm, et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord. 2004 Feb 26;5:6. [3]. Shelly C Lu, et al. S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev. 2012 Oct;92(4):1515-42. [4]. Mosca L, et al. Effects of S‑adenosyl‑L‑methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms. Int J Oncol. 2020 May;56(5):1212-1224. [5]. Ham MS, et al. S-adenosyl methionine specifically protects the anticancer effect of 5-FU via DNMTs expression in human A549 lung cancer cells. Mol Clin Oncol. 2013 Mar;1(2):373-378. [6]. Ornoy A, et al. S-adenosyl methionine prevents ASD like behaviors triggered by early postnatal valproic acid exposure in very young mice. Neurotoxicol Teratol. 2019 Jan-Feb;71:64-74. [7]. Dhediya RM, et al. Evaluation of antiepileptic effect of S-adenosyl methionine and its role in memory impairment in pentylenetetrazole-induced kindling model in rats. Epilepsy Behav. 2016 Aug;61:153-157. |
Chemical & Physical Properties
| Molecular Formula | C19H30N6O10S3 |
|---|---|
| Molecular Weight | 598.67100 |
| Exact Mass | 598.11900 |
| PSA | 288.21000 |
| LogP | 1.97940 |
| InChIKey | TYXBLACMHQBEEW-UHFFFAOYSA-N |
| SMILES | C[S+](CCC(N)C(=O)[O-])CC1OC(n2cnc3c(N)ncnc32)C(O)C1O.O=S(=O)(O)CCCCS(=O)(=O)O |
Synonyms
| Adenosylmethionine 1,4-butanedisulfonate |
